Home » Newsletters » BioWorld Science

BioWorld Science

May 31, 2011

View Archived Issues

Rapid eQuIC assay detects abnormal form of prion protein in tissues and bodily fluids

Novel arylindenopyrimidine compound disclosed

Pfizer files application in Japan seeking additional uses of Diflucan

Unigene Laboratories and Cara Therapeutics form agreement for phase I CR-845 trial

Phosphagenics and 3M complete initial formulation of improved oxycodone transdermal patch

Clinical phase III and preclinical data disclosed on antidepressant Lu-AA-21004

Interim phase II/III analysis points to benefits of Urocidin in non-muscle-invasive bladder cancer

Preclinical data support development of MPI-0485520 for rheumatoid arthritis

Otsuka Pharmaceutical presents new vasopressin receptor antagonists

Rivaroxaban is a viable option for secondary stroke prevention in patients with atrial fibrillation

Filgrastim is safe and may reduce lesion size after recent stroke

Pro-Pharmaceuticals changes name to Galectin Therapeutics

Leo Pharma begins phase II trial of LEO-90100 cutaneous spray ointment for psoriasis

XenoPort begins phase III arbaclofen placarbil trial in multiple sclerosis

MediGene and Johns Hopkins to collaborate on development of vaccine candidates from AAVLP program

ReNeuron completes dosing in first cohort of PISCES trial

BioCis Pharma and Lx Therapies combine to form Laurantis Pharma

TetraLogic closes funding round to advance TL-32711

ProteaBio Europe and Mayoly-Spindler's phase I/IIA MS-1819 trial meets expectations

Nuvilex completes acquisition of pancreatic cancer treatment technology

Pharmascience to expand research and development activities with acquisition of Aegera Therapeutics

OncoSec Medical to begin three phase II trials of ElectroImmunotherapy technology in cancer

Cosmo Pharmaceuticals files MAA in E.U. for Budesonide MMX in active ulcerative colitis

Ono Pharmaceutical to pay PAION second milestone payment with start of phase II remimazolam trial

AstraZeneca and Heptares join to discover and develop GPCR-targeting medicines

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...